Table 1.

Descriptive statistics of the study populationa

CharacteristicsValues
Recipient
    age44.2 (14.3)
    female (%)39.6
    race (%)
        white68.7
        black23.3
        Asian3.7
        other4.3
    history of diabetes (%)30.5
    history of hypertension (%)70.9
    height169.3 (14.0)
    weight73.9 (17.4)
    comorbidity score1.2 (0.8)
    total duration of pretransplantation ESRD (yr)3.3 (3.8)
    total no. of transplants1.2 (0.4)
    cause of ESRD (%)
        diabetes27.1
        hypertension16.2
        glomerulonephritis25.4
        other31.3
    no. of pretransplantation transfusions (%)
        048.2
        1 to 528.1
        6 to 104.1
        >103.0
        unknown16.6
    most recent PRA level (%)4.5 (13.3)
    peak PRA level (%)10.6 (20.0)
    no. of HLA-matched antigens1.8 (1.4)
    % of the ESRD time spent on hemodialysis66.1 (41.8)
    % of the ESRD time spent on peritoneal dialysis23.4 (38.3)
Donor
    living (%)28.8
    age35.6 (15.4)
    female (%)45.4
    black (%)11.7
    height163.2 (26.9)
    weight73.1 (19.5)
    cold ischemia time (hr; %)
        0 to 619.2
        7 to 1416
        15 to 1916.5
        20 to 2415.1
        >2411.1
        missing22.1
    transplantation era (%)
        before 199724
        during or after 199776.0
    maintenance immunosuppressive regimen (%)
        PCM55.2
        PTM23.3
        PCA21.5
  • a Continuous variables presented as mean (SD). PCM, prednisone + cyclosporine + mycophenolate mofetil (MMF); PTM, prednisone + tacrolimus + MMF; PCA, prednisone + cyclosporine + azathioprine; PRA, panel reactive antibodies.